ENSEM Therapeutics

ENSEM Therapeutics

  • Founded: 2021
  • Location: Waltham, MA
  • Employee range: 11 - 50
  • Clinical stage: RD
  • Therapy area: Oncology
  • Drug types: ONC
  • Lead product: Undisclosed
  • Product link: https://ensemtx.com/
  • Funding: $67M A Apr 2022
  • Investors: GGV Capital, Pavilion Capital, Cenova Capital, Mitsui & Co. Global Investment, Inc., CBC Group



job board

Short description:

Characterizing rare conformational states in drug targets

Drug notes:

Contact us to add description.

Long description:

ENSEM Therapeutics is developing precision drugs for oncology targets to address unmet clinical needs. To address oncology, non-obvious binding pockets on difficult-to-drug targets need to be found. Through the use of computational and AI deep learning methodologies combined with advanced experimental techniques, ENSEM has created their Kinetic Ensemble ® platform that identifies cryptic binding pockets and accelerates structure-based drug design. The platform uses data from multiple sources including clinical, imaging, molecular and multi-omics. ENSEM can use their approach to develop innovative small molecule precision medicines for oncology with the potential of targeting other diseases and genetic disorders.


© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com